Ampio Pharmaceuticals Inc.

(NYSE:AMPE)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress.

Contact Information

Website: www.ampiopharma.com
Email: info@ampiopharma.com
Main Phone: +1 720 437-6500
Address: 373 Inverness Parkway
Address 2: Suite 200
State: CO
City / Town: Englewood
Country: US
Postal Code: 80112

Issuer Information

Exchange: AMX
CEO: Michael E. Macaluso
Employees: 18
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A